← Back to headlines
SpyGlass Pharma Reports GAAP EPS of -$5.72
SpyGlass Pharma, Inc. has released its financial results, reporting a GAAP Earnings Per Share of -$5.72.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
